{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T04:16:17Z","timestamp":1761884177709,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.reumae.2022.11.007","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T04:36:25Z","timestamp":1699331785000},"page":"478-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Increased circulating interleukin-23 level in patients with sarcoidosis"],"prefix":"10.1016","volume":"19","author":[{"given":"Senol","family":"Kobak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huseyin","family":"Semiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhittin","family":"Akyildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse","family":"Gokduman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tennur","family":"Atabay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huseyin","family":"Vural","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2022.11.007_bib0120","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","article-title":"Sarcoidosis","volume":"336","author":"Newman","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.reumae.2022.11.007_bib0125","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ccm.2008.03.011","article-title":"Etiology of sarcoidosis","volume":"29","author":"Chen","year":"2008","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.reumae.2022.11.007_bib0130","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0272-5231(05)70415-9","article-title":"Immunology of sarcoidosis","volume":"18","author":"Kataria","year":"1997","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.reumae.2022.11.007_bib0135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1365-2796.2003.01074.x","article-title":"The cytokine network in sarcoidosis and its clinical relevance","volume":"253","author":"Ziegenhagen","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.reumae.2022.11.007_bib0140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1164\/ajrccm.152.1.7599865","article-title":"Cytokines in the bron-choalveolar lavage fluid of patients with active pulmonary sarcoidosis","volume":"152","author":"Girgis","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.reumae.2022.11.007_bib0145","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.reuma.2020.08.007","article-title":"Serum galectin-3 and TGF-beta levels in patients with sarcoidosis","volume":"17","author":"Kobak","year":"2021","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"10.1016\/j.reumae.2022.11.007_bib0150","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.4049\/jimmunol.168.11.5699","article-title":"A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R","volume":"168","author":"Parham","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.reumae.2022.11.007_bib0155","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.coi.2006.09.008","article-title":"The IL-23\/Th(17) axis: therapeutic targets for autoimmune inflammation","volume":"18","author":"Kikly","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.reumae.2022.11.007_bib0160","first-page":"184","article-title":"Cytokines in sarcoidosis","volume":"13","author":"Agostini","year":"1998","journal-title":"Semin Respir Infect"},{"key":"10.1016\/j.reumae.2022.11.007_bib0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaut.2017.12.012","article-title":"Th17-lineage cells in pulmonary sarcoidosis and L\u00f6fgren's syndrome: friend or foe?","volume":"87","author":"Miedema","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.reumae.2022.11.007_bib0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1155\/2011\/185106","article-title":"Association of interleukin 23 receptor gene with sarcoidosis","volume":"31","author":"Kim","year":"2011","journal-title":"Dis Markers"},{"key":"10.1016\/j.reumae.2022.11.007_bib0175","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1183\/09031936.00049410","article-title":"Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes","volume":"37","author":"Fischer","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.reumae.2022.11.007_bib0180","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fimmu.2013.00437","article-title":"Granuloma formation in pulmonary sarcoidosis","volume":"4","author":"Broos","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.reumae.2022.11.007_bib0185","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaad.2011.06.017","article-title":"Molecular profiling and gene expression analysis in cutaneous sarcoidosis: the role of interleukin-12, interleukin-23, and the T-helper 17 pathway","volume":"66","author":"Judson","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.reumae.2022.11.007_bib0190","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2249.2010.04205.x","article-title":"Toll-like receptor (TLR)-9 genetics and function in sarcoidosis","volume":"162","author":"Veltkamp","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.reumae.2022.11.007_bib0195","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/rheumatology\/ker316","article-title":"Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis","volume":"51","author":"Ten Berge","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reumae.2022.11.007_bib0200","doi-asserted-by":"crossref","first-page":"623856","DOI":"10.1155\/2014\/623856","article-title":"Three-dimensional in vitro models of granuloma to study bacteria-host interactions, drug-susceptibility, and resuscitation of dormant mycobacteria","volume":"2014","author":"Fitzgerald","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.reumae.2022.11.007_bib0205","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/thx.2010.140319","article-title":"Sarcoidosis is a Th1\/Th17 multisystem disorder","volume":"66","author":"Facco","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.reumae.2022.11.007_bib0210","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.4049\/jimmunol.162.7.3926","article-title":"Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo","volume":"162","author":"Rogge","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.reumae.2022.11.007_bib0215","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4049\/jimmunol.166.1.642","article-title":"IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs","volume":"166","author":"Shigehara","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.reumae.2022.11.007_bib0220","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2169\/internalmedicine.46.6278","article-title":"Circulating IL-12 p40 is increased in the patients with sarcoidosis, correlation with clinical markers","volume":"46","author":"Hata","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.reumae.2022.11.007_bib0225","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1365-2249.2003.02105.x","article-title":"Increased circulating interleukin-12 (IL-12) p40 in pulmonary sarcoidosis","volume":"132","author":"Shigehara","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.reumae.2022.11.007_bib0230","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1183\/09031936.00000914","article-title":"Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis","volume":"44","author":"Judson","year":"2014","journal-title":"Eur Respir J"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574323000722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574323000722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:03:19Z","timestamp":1761879799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574323000722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2173574323000722"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2022.11.007","relation":{},"ISSN":["2173-5743"],"issn-type":[{"type":"print","value":"2173-5743"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased circulating interleukin-23 level in patients with sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2022.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2022.11.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}